About: http://data.cimple.eu/news-article/dcdaa04ae01d9e5a3390a7be9ceadcb885a1c8f62c304e8c713152eb

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/dcdaa04ae01d9e5a3390a7be9ceadcb885a1c8f62c304e8c713152eb Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The EU said Tuesday it would sign a sixth contract for an upcoming coronavirus vaccine, this time for up to 160 million doses of a jab developed by US firm Moderna. "According to the results of clinical trials, this vaccine could be highly effective against Covid-19," European Commission President Ursula von der Leyen said. "Once the vaccine is indeed proven as safe and effective, every member state will receive it at the same time on a pro rata basis," she said, in a brief statement. Details of the contract, including any purchase options within the 160 million possible total number of doses, will be announced when it is signed on Wednesday. Brussels has previously signed contracts for hundreds of millions of doses of possible future vaccines from Johnson & Johnson, Sanofi-GSK, AstraZeneca, Pfizer-BionNTech and CureVac. Von der Leyen has said that the European Medicines Agency may next month give approval for the most promising vaccines, that have already submitted data from clinical trials. "Between us we are setting up one of the most comprehensive Covid-19 vaccine portfolios in the world. This provides Europeans access to the most promising future vaccines under development so far," she said. "Of course, all vaccines from our portfolio will be evaluated very carefully by our European Medicines Agency, the EMA," she added. "They will be only authorised and placed on the market if they are safe and if they are effective. Transparency here is crucial and of utmost importance." aro-dc/rmb/ach
schema:headline	EU announces latest vaccine contract with Moderna
schema:mentions	President of the European Commission European Commission Renminbi House of Leyen European Medicines Agency Johnson & Johnson Brussels Jab Ursula von der Leyen AstraZeneca European Union Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Pro rata CureVac
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-11-24 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	80 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software